Search

The unique and tailorable physicochemical features of zinc oxide nanoparticles (ZnO-NPs) synthesized from green sources make them attractive for use in cancer treatment. Hydroponic-cultured ginseng-root-synthesized ZnO-NPs (HGRCm-ZnO NPs) were coated with O-carboxymethyl chitosan (CMC) polymer, which stabilized and enhanced the biological efficacy of the nanoparticles. Nanoparticles were characterized by X-ray diffraction (XRD), UV-Vis spectroscopy, transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FT-IR), and energy-dispersive X-ray spectroscopy (EDS). The flower-shaped nanoparticles were crystalline in nature with a particle size of 28 nm. To evaluate if these NPs had anti-lung cancer activity, analysis was performed on a human lung carcinoma cell line (A549). HGRCm-ZnO nanoparticles showed less toxicity to normal keratinocytes (HaCaTs), at concentrations up to 20 µg/mL, than A549 cancer cells. Additionally, these NPs showed dose-dependent colony formation and cell migration inhibition ability, which makes them more promising for lung cancer treatment. Additionally, Hoechst and propidium iodide dye staining also confirmed that the NP formulation had apoptotic activity in cancer cells. Further, to evaluate the mechanism of cancer cell death via checking the gene expression, HGRCm ZnO NPs upregulated the BAX and Caspase 3 and 9 expression levels but downregulated Bcl-2 expression, indicating that the nanoformulation induced mitochondrial-mediated apoptosis. Moreover, these preliminary results suggest that HGRCm ZnO NPs can be a potential candidate for future lung cancer treatment.

Orchid-flower-shaped ZnO nanomaterials were successfully synthesized via green synthesis and an eco-friendly approach using an aqueous extract of Lycium chinense fruit as a reducing and capping agent. The synthesized Lycium chinense orchid-flower-shaped ZnO (LC-ZnO/OF) nanoparticles (NPs) were characterized using different analytical methods through X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy, transmission electron microscopy (TEM), field emission scanning electron microscopy (FE-SEM), photoelectron spectroscopy (XPS), and photoluminescence (PL). The FE-TEM analysis revealed the orchid flower shape of the nanoparticles, and the elemental composition was confirmed via XPS analysis. The photocatalytic activity of the nanoparticles was determined by the degrading cationic dye methylene blue (MB) and the anionic dye Eosin Y (EY) under visible light irradiation at (400 w) within 180 min time, where it showed a significant ability to degrade both cationic and anionic dye by almost 50%. The LC-ZnO/OF photocatalyst was also used to check the toxicity level in human cancer cells, where it exhibited remarkable cytotoxicity to the human lung cancer (A549 cell line) and human gastric adenocarcinoma hyperdiploid (AGS cell line). The present investigation suggests that LC-ZnO/OF has the potential photocatalytic ability to degrade toxic dye as well as have anti-cancer effects. These preliminary results suggest that LC-ZnO/OF could have a significant impact on the environmental and biomedical fields. [ABSTRACT FROM AUTHOR]

Terminalia ferdinandiana (Kakadu plum) is an Australian native plant that has recently gained the attention of researchers due to its highly antioxidant compounds that have substantial health benefits. To raise the value, in this study, it is used for the first time to synthesize ZnO nanoparticles for anti-lung cancer and anti-inflammatory activities. The formation of KKD-ZnO-NPs (ZnO particles obtained from Kakadu plum) were confirmed using a UV-Visible spectrophotometer. Fourier transform infrared (FTIR) spectroscopy analysis confirmed the functional groups that are responsible for the stabilization and capping of KKD-ZnO-NPs. The flower shape of the synthesized KKD-ZnO-NPs was confirmed by field emission-scanning electron microscopy (FE-SEM) and field emission-transmission electron microscopy (FE-TEM) analyses. The crystallites were highly pure and had an average size of 21.89 nm as measured by X-ray diffraction (XRD). The dynamic light scattering (DLS) revealed size range of polydisperse KKD-ZnO-NPs was 676.65 ± 47.23 nm with a PDI of 0.41 ± 0.0634. Furthermore, the potential cytotoxicity was investigated in vitro against human lung cancer cell lines (A549) and Raw 264.7 Murine macrophages cells as normal cells to ensure safety purposes using MTT assay. Thus, KKD-ZnO-NPs showed prominent cytotoxicity against human lung adenocarcinoma (A549) at 10 μg/mL and increased reactive oxygen species (ROS) production as well, which could promote toxicity to cancer cells. Moreover, upregulation of p53 and downregulation of bcl2 gene expression as apoptosis regulators were confirmed via RT-PCR. In addition, KKD-ZnO-NPs possess a similar capacity of reduction in proinflammatory-nitric oxide (NO) production when compared to the L-NMMA as inflammation's inhibitor, indicating anti-inflammatory potential. Incorporation of Kakadu plum extract as reducing and stabilizing agents enabled the green synthesis of flower-shaped KKD-ZnO-NPs that could be an initiative development of effective cancer therapy drug. [ABSTRACT FROM AUTHOR]